Celedonio, Jorge E.
Arnold, Amy C.
Dupont, William D.
Ramirez, Claudia E.
Diedrich, André
Okamoto, Luis E.
Raj, Satish R.
Robertson, David
Peltier, Amanda C.
Biaggioni, Italo
Shibao, Cyndya A.
Funding for this research was provided by:
National Institutes of Health (K23 HL103976)
Autonomic Rare Diseases Clinical Research Consortium Grant (U54 NS065736)
National Center for Research Resources, and the National Institutes of Health (UL1 RR024975)
Article History
Received: 30 March 2015
Accepted: 18 June 2015
First Online: 10 September 2015
Compliance with ethical standards
:
: CAS and IB are consultants for Lundbeck Pharmaceuticals.
: This work was supported in part by grant P01 HL056693, R01 HL102387, Autonomic Rare Diseases Clinical Research Consortium Grant U54 NS065736, the Vanderbilt Clinical and Translational Science Award Grant UL1 RR024975 from the National Center for Research Resources, and the National Institutes of Health. Cyndya A. Shibao is supported by Grant K23 HL103976 from the National Institutes of Health, PhRMA Foundation Career Development Award, Doris Duke Clinical Scientist Career Development Award.